Kidney Cancer Treatment Drugs
If your tumor is less than 1 5 inches your doctor might suggest watchful waiting sometimes called active surveillance this.
Kidney cancer treatment drugs. For cancers confined to the kidney this may be the only treatment needed. Data sources include ibm watson micromedex updated 30 june 2020 cerner multum updated 1 july 2020 wolters kluwer. This material is provided for educational purposes only and is not intended for medical advice diagnosis or treatment. Afinitor everolimus afinitor disperz everolimus aldesleukin.
In 2018 the fda approved using these drugs in combination as checkpoint inhibitors to. Doctors at nyu langone may prescribe a variety of medications to treat kidney cancer. Targeted drugs used to treat advanced kidney cancer sunitinib sutent sorafenib nexavar pazopanib votrient cabozantinib cabometyx lenvatinib lenvima bevacizumab avastin axitinib inlyta temsirolimus torisel everolimus afinitor. Investigational drugs might be considered for certain eligible patients if other approved options have already been tried or if there is an investigational combination treatment of two approved drugs for kidney cancer.
Chemotherapy chemo uses anti cancer drugs that are given into a vein iv or taken by mouth as pills. Drugs approved for kidney renal cell cancer. These drugs show promise in treating kidney cancer that has spread to other areas of the body. Recent breakthroughs in kidney cancer treatments include the immunotherapy drugs ipilimumab and nivolumab.
The targeted drugs cabozantinib cabometyx axitinib inlyta bevacizumab avastin pazopanib votrient sorafenib nexavar and sunitinib sutent block signals that play a role in the growth of blood vessels that nourish cancer cells and allow them to spread. If the cancer has spread beyond the kidney additional treatments may be recommended. They are usually used to manage advanced kidney cancer that has spread to other parts of the body such as the lungs bone or liver. Nyu langone is one of the only medical centers in the new york area to use high dose immunotherapy.